Evidence map›Paper›PMID 42112238›Full record

ArticlemicroPublication biology2026

Long-term cultivation shifts transcriptomic profile of HCT-116 cells.

Gudrun Marquardt, Theresa Wießner-Kroh, Stefan Rubner, Ioannis Papasotiriou

Abstract read
In one paragraph

Article in microPublication biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Gudrun Marquardt *Research Genetic Cancer Centre Central Europe GmbH, Weinbergweg 22, D-06120 Halle (Saale), Germany.
Theresa Wießner-Kroh *Research Genetic Cancer Centre Central Europe GmbH, Weinbergweg 22, D-06120 Halle (Saale), Germany.
Stefan RubnerResearch Genetic Cancer Centre Central Europe GmbH, Weinbergweg 22, D-06120 Halle (Saale), Germany.
Ioannis PapasotiriouResearch Genetic Cancer Centre International GmbH, Baarerstrasse 95, CH-6300 Zug, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human cancer cell lines are widely used in artificial culture systems to study cancer biology due to their immortalization, enabling extended culturing compared to primary cells. However, genomic instability can rapidly alter cellular behavior, raising questions about the transcriptome stability for controlled studies. We cultivated HCT-116 cells over 25 passages (~16 weeks), and observed a stable transcriptome up to passage 20, with only minimal differential gene expression. Above passage 20, genes corresponding to cell proliferation and cell death were upregulated suggesting a change in general cellular regulation and underlining defined cell culture time periods for stable and reproducible experimental conditions.

Identifiers

PMID42112238
PMCPMC13150749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.